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Abstract
Quantitative gait analysis has revealed that a large proportion of horses in training, per-
ceived as free from lameness by their owners, show movement asymmetries of equal mag-
nitude to horses with mild clinical lameness. Whether these movement asymmetries are
related to orthopaedic pain and/or pathology has yet to be further investigated. Therefore,
the objective of this study was to determine whether movement asymmetries in riding
horses in training are affected by anti-inflammatory treatment with meloxicam. In a cross-
over design, horses were treated with meloxicam or placebo for four days respectively, with
a 14–16 day washout period between treatments. Objective movement analysis utilising
body mounted accelerometers was performed on a hard and a soft surface before and on
day four of each treatment. A trial mean was calculated for the differences between the two
vertical displacement minima and maxima of head (HDmin, HDmax) and pelvis (PDmin,
PDmax) per stride. Horses (n = 66) with trial mean asymmetries greater than 6 mm for
HDmin or HDmax, or more than 3 mm for PDmin or PDmax, at baseline were included. The
difference before and after each treatment in the measured movement asymmetry was
assessed with linear mixed models. Treatment with meloxicam did not significantly affect
the movement asymmetry in any of the models applied (all p>0.30). These results raise new
questions: are the movement asymmetries in riding horses in training simply expressions of
biological variation or are they related to pain/dysfunction that is non-responsive to meloxi-
cam treatment?
Introduction
Disorders of the locomotor apparatus are collectively the most common reason for equine vet-
erinary consultation [1,2]. They are also the most common cause of euthanasia in the Swedish
riding horse population [3].
A major shortcoming of subjective visual assessment of lameness is the low inter-observer
agreement [4–7], probably in part due to limitations of the human visual perception of
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asymmetry [8,9]. Several movement symmetry based objective systems have been developed
(for a review see Serra Braganc¸a, Rhodin and van Weeren [10]) with the aim of obtaining a
more accurate detection of lameness. Studies indicate that these systems might be more sensi-
tive for detection of low grade lameness when compared to subjective lameness evaluation by
experienced observers [11–13].
However, the currently recommended thresholds [14] for one of these movement symme-
try based objective systems frequently result in a classification of horses in training and per-
ceived as free from lameness by their owner, as asymmetric. In a prevalence study of 222
riding horses in training, 73% had movement asymmetries [15] with median asymmetry
values for both forelimbs and hind limbs in the same range as in horses with clinically relevant
movement deficits measured with the same objective system [16,17]. Other studies detected
asymmetries exceeding the aforementioned thresholds in 47% of 201 [18], or values outside
normal ranges according to Buchner et al. [19] in 67% of 27 [20] riding horses in training.
Using subjective lameness assessment 53% of 57 [21] and 38% of 506 [22] horses in regular
work were classified as lame, suggesting that this finding is also inherent to subjective scoring
systems.
It is currently unclear to what extent movement asymmetries are related to pain and/or
pathology or whether they may represent natural biological variation in the movement pat-
terns of these horses. Thus, the relation between clinically significant movement asymmetry
and biological variation of movement symmetry needs to be investigated further. It is of partic-
ular interest to investigate methods for reliable discrimination between asymmetry and lame-
ness as early detection of orthopaedic diseases is integral to avoid progression into chronic
states of disease that carry a poor prognosis for recovery in spite of treatment. If movement
asymmetries in horses in training are decreased by treatment with a nonsteroidal anti-inflam-
matory drug, it would be reasonable to assume that such asymmetries are due to pain from an
underlying unrecognized inflammatory process.
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class and acts
by inhibition of prostaglandin synthesis via preferential COX-2 (inducible cyclooxygenase iso-
form) inhibition [23]. Oral suspension of meloxicam is approved in the European Union since
1998 [24] for the treatment of acute and chronic locomotive disorders in equines and is com-
monly used in many European countries with this indication. In horses with experimentally
induced lameness from lipopolysaccharide-induced joint inflammation, meloxicam treatment
has been shown to result in a reduction in visual lameness scores [25–27], a reduction in head
movement asymmetry [27] and in a suppression of synovial fluid markers of inflammation,
MMP activity and cartilage turnover [25] when compared to placebo. In horses with clinical
musculoskeletal pain, meloxicam was slightly more effective in alleviating lameness than veda-
profen [28]. Collective evidence thus suggests that meloxicam reduces musculoskeletal pain of
inflammatory origin.
The aim of this study was to determine whether movement asymmetries in riding horses,
in training and perceived as free from lameness by their owner, are affected by anti-inflamma-
tory treatment with meloxicam. The hypothesis was that, if a proportion of the horses selected
for the study suffered from musculoskeletal pain of inflammatory origin, meloxicam treatment
would decrease the degree of movement asymmetry on a group level.
Materials and methods
The study protocol was approved by the Ethical Committee for Animal Experiments, Uppsala,
Sweden, application number C 48/13 and C 92/15. Informed written consent was obtained
from all horse owners. Data collection was performed during the years 2013–2016.
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Horses
Convenience sampled warmblood riding horses (privately owned, horses belonging to two
equestrian centres and two riding schools) stabled in the vicinity of the University of Agricul-
tural Sciences in Uppsala were screened for movement asymmetry using a commercially avail-
able inertial measurement unit (IMU) sensor system (Lameness Locator, Equinosis, Columbia,
MO, USA). Screened horses were included based on the following criteria: 1. they were in full
training; 2. they were considered free from lameness by their owner; 3. they had not been
treated for lameness during the two months preceding data collection. Horses presenting with
asymmetry values above thresholds previously used in a prevalence study [15] for head (abso-
lute value >6 mm) or pelvic (absolute value>3 mm) parameters were included in the study.
The values were obtained from measurements on hard and/or soft surface, at the preferred
speed of each horse trotted in-hand on the straight. Horses considered too lame (>2 degrees
on a 0–5 ordinal scale) to continue their normal training at inclusion or at a later time point
during the study, were excluded from the study, at the discretion of the study veterinarians.
Study design
In a crossover design, each horse was treated with meloxicam or placebo for four days respec-
tively followed by a 14–16 day washout period between subsequent treatments (Fig 1). The
order of the two treatments was randomly assigned to each horse. The owners were blinded to
the order in which their horse received each treatment and were instructed to continue train-
ing according to their normal regime.
Objective movement symmetry data was collected at four time points during the study:
before treatment on day 1 and after treatment on day 4 of each treatment period (Fig 1). All
horses were trotted in hand on a straight line and lunged on a circle with a diameter of 10 m
and 15 m (markers placed on the lunge line) in both directions. All conditions were performed
twice, at two different speeds, slow (preferred speed) and fast, as judged subjectively. All condi-
tions were also conducted on two different surfaces; a hard surface, usually consisting of
packed dirt or occasionally asphalt, and a soft surface, usually an indoor arena or occasionally
an outdoor arena. Surfaces thus differed between horses but were kept consistent for each indi-
vidual horse throughout the study. In total, measurements were obtained under 16 different
conditions for each horse at each time point. Each horse was randomly allocated to start with
Fig 1. Study design.
https://doi.org/10.1371/journal.pone.0221117.g001
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either of a hard/soft surface, a left/right direction and circles/straight lines. The order in which
the conditions were performed throughout the study was kept consistent for each horse. In the
event of technical equipment malfunctioning or uncooperative behaviour from the horse, the
condition was repeated until successful data collection was completed. In the present study,
only data collected from straight line in-hand trot and from the 10m lunge circles, both in pre-
ferred speed, were used.
Drug administration, plasma sample collection and analysis
Meloxicam (Inflacam, Virbac, Kolding, Denmark) at the recommended dose of 0.6 mg/kg or
placebo (vanilla yoghurt with similar colour and smell) was administered per os once daily on
day 1–4 of each treatment period. The weight of each horse was assessed by means of a weight
tape. Owners and riders were blinded to the order of the treatments. Treatment was adminis-
tered by one of the researchers directly after the baseline movement symmetry measurement
on day 1, given once daily by one of the researchers or a local stable representative (not the
rider or owner) on days 2–3 and administrated by one of the researchers 1–6 hours before
measurement on day 4. Plasma samples to confirm adequate meloxicam concentration were
obtained by venipuncture immediately after the movement symmetry measurement on day 1
and day 4. Blood samples were collected in two lithium heparin tubes (4 ml each), plasma sepa-
rated by centrifugation and stored at -80˚C until analysis. Plasma samples were analysed by
use of high-performance liquid chromatography with tandem mass spectrometry detection
(HPLC-MS/MS, Recipharm OT Chemistry AB, Uppsala, Sweden, lower detection limit 10 ng/
mL). Horses with plasma concentrations above 195 ng/mL (which is the previously published
plasma concentration for reduction in lameness score [26]) after meloxicam treatment or
below 20 ng/mL during any of the other sample times were included in further analysis.
Instrumentation
The IMU system used for collection of objective motion symmetry data consisted of three sensors.
One uni-axial gyroscope with a range of 300˚/s was attached with a specially designed pastern
wrap to the dorsal side of the right forelimb pastern. Two uni-axial accelerometers with a range of
6 g were then attached, one to the poll with a felt head bumper and one taped to the midline
between the two tubera sacrale. The sensors measured 3.2 x 3.0 x 2.0 cm and had a mass of 28 g.
Data was digitally recorded (8 bits) at 200 Hz and wirelessly transmitted to a handheld computer.
Data processing
The software included in the IMU system was used for analysis of the sensor data. Recorded
vertical acceleration from the head and pelvis sensor was converted to vertical displacement
using a moving-window, error correcting, and double integration algorithm as described by
Keegan et al. [14]. Stride splitting was performed based on angular sagittal plane velocity data
from the limb mounted sensor’s gyroscope. Trial means of the stride-by-stride difference of
the local displacement minima for the head (HDmin) or pelvic (PDmin) height between right
and left limb stances were calculated. Similarly, HDmax and PDmax were calculated as the
trial means of the stride-by-stride difference of the maximum head or pelvic height prior to
right limb stance minus the maximum head or pelvic height prior to left limb stance. Positive
values thus indicate less downward movement during stance or less upward movement pro-
duced in the push off phase (lower maximum position reached) of the right forelimb or hind
limb and negative values represent asymmetries attributed to the left forelimb/hind limb.
The custom written software also aims to correct for the size of the horse by normalizing
the stride-by-stride difference to the total vertical range of motion for each stride before the
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aforementioned trial means are calculated. Plots of HDmin and HDmax in the software output
were scrutinized and outliers (up to maximum 10% of the strides) were removed.
Statistical analysis
Data from all horses were analysed using open software (R, version 3.5.1, The R Foundation
for Statistical Computing, Vienna, Austria). Mixed models were created using the lme function
in the nlme package. Normality of residuals was verified using q-q plots and homoscedasticity
was ensured by plotting the residuals against the fitted values. The level of significance was set
to P<0.05. HDmin/HDmax are approximately twice in magnitude compared to PDmin/
PDmax at the same degree of subjectively perceived lameness [29] and the thresholds for
asymmetry used in this study also show this relationship. In order to avoid this resulting in
selection of only forelimb asymmetry when selecting each horse’s main asymmetry as below,
equal weight needed to be given to both head and pelvic parameters. Therefore, both for selec-
tion of main asymmetry and in the statistical models outlined below, head parameters were
halved. The final values used were thus absolute values of HDmin/2, HDmax/2, PDmin and
PDmax.
Six statistical models were implemented; three for each surface type (soft and hard). One
model each for straight line data, one model each for lunge data and one model each for the
30% most asymmetric horses.
Only horses with at least one asymmetry parameter value exceeding the previously
described thresholds in the ‘Baseline 1’ straight line measurement, for the surface type evalu-
ated, were included in the models for that surface.
• Straight line models: To assess the effect of meloxicam on the horses’ main asymmetry, the
asymmetry parameter (HDmin/2, HDmax/2, PDmin or PDmax) with the highest absolute
value at ‘Baseline 1’ was selected for each horse. Outcome variable was the difference in abso-
lute value before and after each treatment for this main asymmetry parameter.
• Lunge models: These two models aimed to assess the effect of meloxicam on asymmetry
shown on the lunge. The direction on the circle in which each horse’s main asymmetry was
highest in absolute value and indicated the same limb as on the straight line was selected.
For a horse with a PDmin main asymmetry attributed to the right hind in straight line
‘Baseline 1’, the direction on the circle in which the absolute value of PDmin was greatest
and attributed to right hind was chosen. Outcome variable was the difference in absolute
value of the main asymmetry parameter in the selected lunge direction before/after each
treatment.
• Top 30% most asymmetric horses: To assess whether meloxicam had an effect in horses with
more prominent asymmetries, the horses with the top 30% highest values for their main
asymmetry parameter were included in a subset of data analysed separately. Outcome vari-
able again was the difference in absolute value before and after each treatment for the main
asymmetry parameter in the selected subset in straight line trot.
In all six models, treatment was entered as fixed effect along with the difference in stride
frequency before and after each treatment as a covariate. Horse was entered as a random effect
(random intercept) in all models. Box plots were created for the data underlying each model
illustrating the difference in main asymmetry before and after each treatment. Plots showing
median values (horizontal bold line), 25th and 75th percentile (interquartile range, IQR,
box limits), notches (extending 1.58�IQR/sqrt(n)), (whiskers (thin lines) extending to median
+/-1.5�IQR and extreme values outside the area covered by the whiskers.
Effect of meloxicam treatment on movement asymmetry in riding horses in training
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Results
A total of 140 horses were initially screened. Out of these 32 did not present with motion asym-
metries, five were excluded due to being too difficult to handle, three due to being judged as
too lame (>2 degrees on a 0–5 ordinal scale) to continue their normal training and 18 due to
inability to comply with the logistics of the study plan. Thus 82 horses with asymmetry values
above the previously mentioned thresholds were initially selected for participation in the
study. Sixteen horses were later excluded, during the study time: six due to being judged as too
lame to continue their normal training, two due to being too difficult to handle and one due to
planned competitions within the withdrawal time. One horse was excluded due to missing
data for straight line measurements on both surfaces. Six horses were excluded due to meloxi-
cam plasma concentrations below 195ng/mL after meloxicam treatment; or above 20ng/mL
during any of the other sample times.
This resulted in inclusion of a total of 66 horses with 41 geldings and 25 mares, mean
(range) age 11 years (3–22 years), height at withers 167 cm (152–180 cm), body mass 598 kg
(460–750 kg). Horses included consisted of privately owned horses (n = 27), horses owned by
the National Equestrian Center at Stro¨msholm (n = 17), by the Swedish Horse Guards Society
(n = 12), and by two riding schools (n = 10). Horses were used for dressage (n = 22), show
jumping (n = 21), or were all-round horses (n = 22) and one horse was used for eventing. For
details of the individual horses included in the study see S1 File. The horses were not treated
for lameness during six months preceding the study with the exception of two horses (treated
two and four months preceding the study, respectively).
Determination of each horse’s main asymmetry, i.e. the asymmetry parameter with the
highest absolute value at ‘Baseline 1’, resulted in selection of more hind limb asymmetries
(72% on hard surface and 64% on soft surface) than forelimb asymmetries (Table 1). Of all the
asymmetries recorded above the threshold values present in all horses, i.e. not just the main
asymmetries, hind limb asymmetries were similarly found more commonly than forelimb
asymmetries. For some horses different asymmetry parameters were included in each model,
for example PDmin was included in the model for the soft surface and HDmin for the hard
surface. Some horses showed asymmetry values above the threshold for only one surface and
were thus not included in the model for the other surface. One horse was excluded from the
soft surface straight line model, one other from the hard surface straight line model and one
other from the soft surface lunge model due to missing data. In the end, this resulted in 57
horses in the models for the hard surface and 58 in the models for the soft surface out of the 66
horses originally included. All included horses (n = 66) remained in at least one model.
Table 1. Prevalence of different asymmetries in straight line trot at ‘Baseline 1’ measurement in the horses included in the study.
Hard surface Soft surface
Parameter All > threshold Selected main asymmetry All > threshold Selected main asymmetry
n of horses median IQR n of horses median IQR n of horses median IQR n of horses median IQR
HDmin 22 8.7 2.4 9 8.8 5.0 24 9.1 3.0 10 10.6 5.8
HDmax 20 8.9 2.4 7 8.9 2.3 26 8.5 3.9 11 8.6 3.4
PDmin 31 4.7 2.6 24 5.0 2.3 31 5.0 2.1 19 5.3 2.6
PDmax 32 4.6 2.1 17 5.2 2.0 31 4.6 2.1 18 5.4 3.4
Total 57 58
Distribution of the selected main asymmetries and the total number of horses with asymmetries above the thresholds (for the head absolute value >6 mm and pelvis
absolute value >3 mm) for each asymmetry parameter in straight line trot. The median and IQR (interquartile range) of the absolute values for the asymmetries are also
shown, head parameters are original values and not divided by two as in the statistical models.
https://doi.org/10.1371/journal.pone.0221117.t001
Effect of meloxicam treatment on movement asymmetry in riding horses in training
PLOS ONE | https://doi.org/10.1371/journal.pone.0221117 August 13, 2019 6 / 14
Minor deviations from the standard protocol included the following: Differences in order
of conditions between measurement time points (n = 6), increased or slightly decreased wash-
out period (n = 13), placebo treatment increased by one day (n = 5).
The effect of treatment with meloxicam was not statistically significant in any of the six
mixed models created. Neither the main asymmetry on the straight (Fig 2) nor on the lunge in
the direction where this asymmetry had been most evident at baseline (Fig 3) were significantly
affected. There was also no significant effect of treatment found for the top 30% most asym-
metric horses in straight line trot (Table 2 and Fig 4).
The difference in stride rate significantly affected the difference in asymmetry in the model
that investigated the movement asymmetry on the lunge on the soft surface. The model esti-
mate showed that a decrease of 0.01 strides/s in stride rate led to a 0.2868 mm decrease in
asymmetry (p = 0.007). The mean (SD) difference in stride rate on the lunge on soft surface
was -0.01 strides/s (0.03), i.e. a small decrease over the 4 day treatment period averaged over
both treatments. For values of stride frequency before and after each treatment see Table 3.
A considerable variation over time for the selected main asymmetry parameters was evident
in some horses while others showed less variation (Fig 5). The mean absolute difference
between consecutive time points across all horses for straight line assessments was median
Fig 2. Effect of treatment on the main asymmetry parameter of the horses in straight line trot. Shown here is the
difference in the main asymmetry parameter between pre-treatment on day 1 and post treatment on day 4 of each
treatment (meloxicam and placebo) across 57 horses on hard surface and 58 horses on soft surface. Negative values
represent a reduction in asymmetry during the treatment period. No significant effect of treatment was found (p = 0.31
for hard surface and p = 0.48 for soft surface).
https://doi.org/10.1371/journal.pone.0221117.g002
Fig 3. Effect of treatment on the main asymmetry parameter of the horses on the lunge. Shown here is the
difference in the main asymmetry between pre-treatment on day 1 and post treatment on day 4 of each treatment
(meloxicam and placebo) in the direction on the lunge where the main asymmetry parameter of each horse was most
evident at ‘Baseline 1’. Negative values represent a reduction in asymmetry during the treatment period with 57
included horses on hard surface and 58 included horses on soft surface. No significant effect of treatment was found
(p = 0.63 for soft surface and p = 0.75 for hard surface).
https://doi.org/10.1371/journal.pone.0221117.g003
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(interquartile range) 3.7 mm (6.5 mm) for head asymmetry parameters and 1.4 mm (1.9 mm)
for pelvic asymmetry parameters respectively on hard surface and 3.8 mm (5.2 mm) for head
and 1.6 mm (2.0 mm) for pelvic parameters respectively on soft surface (based on original val-
ues, i.e. head parameters not divided by two).
Discussion
In this study, we have assessed the effect of treatment with meloxicam on movement asymme-
tries in warmblood riding horses in full training, considered free from lameness by their own-
ers, and not recently treated for lameness. Interestingly, no significant effect of treatment on
movement asymmetry was found in any of the six mixed models. This suggests that either the
movement asymmetries in these horses are not generally caused by pain, but rather derives
from biological variation, such as laterality or conformation, or treatment with meloxicam did
not effectively moderate existing pain.
Meloxicam is commonly used in equine practice for the treatment of lame horses with
orthopaedic disorders or for analgesic testing. It is a selective COX-2 inhibitor [23] and is
expected to be effective in alleviating pain of inflammatory origin via reduction of prostaglan-
din synthesis. The non-responsiveness of the horses in the present study thus makes pain of
Table 2. Prevalence of different asymmetries in straight line trot in the highly asymmetric subset at ‘Baseline 1’.
Hard surface Soft surface
Selected main asymmetry Selected main asymmetry
n of horses median IQR n of horses median IQR
HDmin 3 15.2 8.7 3 14.6 1.6
HDmax 1 12.4 0 1 17.3 0
PDmin 8 7.8 2.1 7 7.7 0.8
PDmax 5 6.7 0.9 6 9.0 2.2
Total 17 17
Distribution of horses across the selected main asymmetries in straight line trot for the subset (30%) of horses showing the highest degree of asymmetry. The median
and IQR (interquartile range) of the absolute values for the asymmetries are also shown. Head parameters are original values and not divided by two as in the statistical
models.
https://doi.org/10.1371/journal.pone.0221117.t002
Fig 4. Effect of treatment in the top 30% most asymmetric horses in straight line trot. Shown here is the difference
between pre-treatment on day 1 and post treatment on day 4 of each treatment (meloxicam and placebo) in the main
asymmetry parameter in the top 30% horses (n = 17) with the highest degree of asymmetry. Negative values represent a
reduction in asymmetry during the treatment period. No significant effect between treatments was found (p = 0.75 for
soft surface and p = 0.50 for hard surface).
https://doi.org/10.1371/journal.pone.0221117.g004
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acute inflammatory origin a less likely cause of the movement asymmetries. However, it does
not exclude other types of pain being present such as chronic or neuropathic pain. In addition
meloxicam has also been shown to be ineffective in reducing pain in a hoof pressure lameness
model [27], which would be expected to be a predominantly nociceptive (mechanical) pain.
Keegan et al. [30] evaluated the effect of phenylbutazone alone or in combination with flunixin
meglumine on objectively measured lameness in a heterogeneous sample of horses with natu-
rally occurring chronic lameness (of at least 4 months duration). On a group level, no effect
was detected for phenylbutazone alone; however phenylbutazone in combination with flunixin
meglumine resulted in decreased movement asymmetry. This suggests that pain in chronic
lameness, non-responsive to one single class of NSAID, may be alleviated by combination
treatment. Thus, treatment with only meloxicam, as in the present study, may not be potent
enough to obtain a group level effect in chronic lameness cases.
In the present study, four movement asymmetry parameters for the vertical excursion of
the head and pelvis were quantified to evaluate the effect of treatment. These parameters are
Table 3. Stride frequency.
Hard surface
Straight Circle
Baseline Post treatment Baseline Post treatment
Meloxicam 1.37 (0.10) 1.35 (0.11) 1.29 (0.08) 1.27 (0.10)
Placebo 1.35 (0.12) 1.36 (0.11) 1.29 (0.10) 1.29 (0.10)
Soft surface
Straight Circle
Baseline Post treatment Baseline Post treatment
Meloxicam 1.35 (0.11) 1.35 (0.12) 1.26 (0.11) 1.25 (0.10)
Placebo 1.35 (0.11) 1.37 (0.13) 1.26 (0.07) 1.26 (0.10)
Median (interquartile range) for stride frequency in strides/sec on the straight and circle before and after each treatment.
https://doi.org/10.1371/journal.pone.0221117.t003
Fig 5. Example of variation in asymmetry over time. Change in each horse’s main asymmetry parameter across
measurement time points on a hard surface, straight line. Original values are shown here (signed negative for left and
positive for right sided asymmetries). Head parameters are not divided by two. For better visualisation, n = 4 outliers
have been removed (outside of graph boundaries).
https://doi.org/10.1371/journal.pone.0221117.g005
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associated with ground reaction force asymmetries [31–32] and are sensitive indicators of lame-
ness in horses [33–37]. Validated thresholds for the discrimination between symmetric and
asymmetric movement under different conditions has yet to be developed. In our study, we used
the same thresholds for straight line trot as described in a previous prevalence study [15]. They
are also recommended by the system developer as thresholds for detecting clinical lameness in
conjunction with a full lameness examination and are similar to published confidence intervals
for repeatability of asymmetries with the IMU system used [14]. This ensures that the categoriza-
tion of movement asymmetries of our study can be compared to asymmetries described in other
populations, including the populations where the same IMU system is used during clinical lame-
ness exams. The variation in movement asymmetries over time in both sound and lame horses
futher discussed below [38–40] should also be taken into consideration, and more research is
needed to establish guidelines for use of IMU thresholds for various purposes.
In the first two models (one for each surface type) we chose to follow the evolution of the
main asymmetry parameter that was determined for each horse at the time of inclusion in the
study. Since four asymmetry parameters were measured simultaneously, each horse may have
shown values above the thresholds for one or multiple asymmetry parameters. Selecting the
most prominent asymmetry parameter might increase the chances of finding an effect of treat-
ment in so far that possible concurrent increases in the other three asymmetry parameters dur-
ing treatment are being ignored. Selecting the asymmetry with the highest magnitude also
maximises the chances of selecting a parameter that is associated with a primary lameness, if
present, and not a parameter describing compensatory movements of the head or pelvis result-
ing from a primary lameness in one of the other limbs [16,17,35,36]. Using absolute values
enables a combination of left and right sided asymmetries but conceals any changes in the side
of asymmetry, i.e. changes between the left and the right limb being unloaded. However, as
only a small number of horses changed in the side of their main asymmetry in this study (Fig
5), this is not likely to have resulted in a major impact on the models.
In the third and fourth model the effect of treatment on the main asymmetry measured on
a circular path was tested. In analogy to the first two models, the main asymmetry parameter
of each horse measured at ‘Baseline 1’ was selected, and the measurement from the circle direc-
tion where it was most evident at ‘Baseline 1’ was used in the analysis. This choice was based
on the previous finding that circle induced gait adaptations previously shown [18,20,36,41] are
likely to increase the asymmetry selected for analysis in one direction and decrease it in the
opposite direction, thus potentially concealing any effect, if both directions were included in
the response variable.
The failure to detect a significant effect of meloxicam on movement asymmetry might also
be due to the study population which may have included a mixture of horses both with and
without pain related movement asymmetries. We therefore created a subset containing the top
30% most asymmetric horses. With higher degrees of asymmetry, our assumption was that the
probability of an underlying painful pathology being present would increase. Compared to
asymmetries in clinically lame horses responsive to diagnostic analgesia [16,17], the degrees of
asymmetry in these subsets of horses are similar for the forelimb related parameters and higher
for the hind limb related parameters. However, in the present study, no treatment effect was
found in these two models either. This finding further suggests that either meloxicam does not
effectively reverse pain in these horses or the measured asymmetries are not due to pain. In the
model using data from the lungeing condition on the soft surface, the difference in stride fre-
quency significantly affected the difference in movement asymmetry. A small mean decrease
in stride frequency during treatments resulted in a small mean decrease in asymmetry. Stride
frequency is closely related to speed which has been reported to influence asymmetry parame-
ters on the lunge but not on the straight line [42–43]. A decrease in asymmetry due to a
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decrease in stride frequency, approximating a decrease in speed, is in agreement with the
results in Starke et al. [43].
The majority of soft surface measurements were obtained using indoor arenas, where sur-
faces were expected to be fairly consistent over time. In locations where an indoor arena was
not available, outdoor paddocks with a sand surface were used. Outdoor paddocks are inher-
ently subjected to more variability due to weather conditions. However, the location of mea-
surement (indoor vs outdoor) was kept consistent for each horse. Some owners owned a large
number of included horses but each horse was ridden and trained by different rider or riders,
thus training effects were expected to differ. Inclusion bias cannot be completely excluded in
the present study, as owners suspecting a problem related to the locomotor apparatus may
have been more motivated to volunteer their horse for participation in the study. However, a
major impact of this possible bias on outcome is unlikely as the median values of movement
asymmetry and the proportion of horses with values above the threshold for each of the asym-
metry parameters correspond to findings in a prevalence study of a comparable population of
horses [15]. Furthermore, the effect of inclusion bias in the present study would arguably have
been an increased chance of finding an effect of meloxicam.
A number of horses in this study showed considerable variation over time in the measured
asymmetries. This variation occurred irrespective of treatment (Fig 5), and across a relatively
short period of data collection. Similar to this study a substantial variation in movement asymme-
tries over time has previously been shown in sound riding horses [38] and thoroughbreds deemed
fit to train by their trainers [39]. In lame horses, the variation has so far only been studied between
two consecutive days in horses with forelimb lameness [40] but also showed considerable day-to-
day variation. If generally true in lame horses, this phenomenon has to be considered when evalu-
ating the response to treatment in a clinical setting and when assessing a horse for soundness, for
example during a pre-purchase examination, warranting further studies in the future.
In summary, the results and subsequent issues raised above warrant further investigation
into the underlying cause(s) of the movement asymmetries exceeding pre-defined threshold
values measured in horses in training. One possible way forward to confirm or rule out the
presence of pain might be the use of diagnostic analgesia to identify possible pain loci in the
lame limb. It may also be worth investigating alternative systemic analgesic treatments regi-
mens and advanced imaging modalities. If then, underlying painful pathologies are identified
in a large proportion of horses, the presence of movement asymmetry should be regarded as a
severe welfare problem. If, on the other hand, no underlying pathologies linked to pain are
identified, the conclusion may be that these asymmetries are due to biological variation as
motor laterality or conformational asymmetries. In order to avoid unnecessary lameness
examinations or to avoid erroneously failing horses during pre-purchase examinations, this
remains an important research question.
Conclusions
Treatment with four days of meloxicam did not significantly decrease the movement asymme-
try measured in the horses in training included in this study. However, such a finding does not
exclude that pain may be present. Therefore, the present study raises new questions with
regards to whether such asymmetries are simply expressions of biological variation or related
to pain/dysfunction not responsive to meloxicam treatment.
Supporting information
S1 File. Data sets used for the data analysis. Excel book containing sheets with the data sets
used. Sheet ‘Full dataset’ contains data for all the 66 included horses. Sheet ‘Straight line hard
Effect of meloxicam treatment on movement asymmetry in riding horses in training
PLOS ONE | https://doi.org/10.1371/journal.pone.0221117 August 13, 2019 11 / 14
surface, ‘Straight line soft surface, ‘Lunge hard surface’, ‘Lunge soft surface’, ‘Top 30% hard
surface’ and ‘Top 30% soft surface’ contains the subsets and calculated extra variables used in
each of the six mixed models.
(XLSX)
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